These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17619772)

  • 1. Hope and challenges in the management of advanced renal cell carcinoma.
    Clark P
    ScientificWorldJournal; 2007 May; 7():869. PubMed ID: 17619772
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytokine-based immunotherapy for advanced kidney cancer: past results and future perspectives in the era of molecularly targeted agents.
    Porta C; Paglino C; Imarisio I; Bonomi L
    ScientificWorldJournal; 2007 Apr; 7():837-49. PubMed ID: 17619768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New agents for the treatment of renal cell carcinoma.
    Tian GG; Dawson NA
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):546-54. PubMed ID: 12113087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy strategies for advanced renal cell carcinoma].
    Staehler M; Haseke N; Schöppler G; Stadler T; Adam C; Stief CG
    Urologe A; 2006 Jan; 45(1):99-110, quiz 111-2. PubMed ID: 16372186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney cancer: neoadjuvant targeted therapies in renal cell carcinoma.
    Ficarra V; Novara G
    Nat Rev Urol; 2010 Feb; 7(2):63-4. PubMed ID: 20145660
    [No Abstract]   [Full Text] [Related]  

  • 6. The future of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma in the era of target-specific therapy.
    Ueno NT; Cheng YC
    Bone Marrow Transplant; 2006 Dec; 38(11):711-4. PubMed ID: 17106451
    [No Abstract]   [Full Text] [Related]  

  • 7. Managing the complex journey of renal cell carcinoma.
    Amen K
    ONS Connect; 2007; 22(8 Suppl):53-4. PubMed ID: 17824565
    [No Abstract]   [Full Text] [Related]  

  • 8. Neoadjuvant targeted therapy in renal cell carcinoma.
    Iacovelli R; Raimondi C; Palazzo A; Cortesi E; Procopio G
    Nat Rev Urol; 2010 Jul; 7(7):doi:10.1038/nrurol.2010.2-c1; author reply doi:10.1038/nrurol.2010.2-c2. PubMed ID: 20665981
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal cell carcinoma: urologists in a new era.
    Uzzo RG
    J Urol; 2005 Nov; 174(5):1723-4. PubMed ID: 16217270
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal cell carcinoma: today's targeted therapies improving tomorrow's outcomes.
    Biedrzycki BA
    ONS News; 2006; 21(8 Suppl):21-2. PubMed ID: 16925136
    [No Abstract]   [Full Text] [Related]  

  • 11. Allogeneic peripheral blood stem cell transplantation for metastatic renal cell carcinoma.
    Rini BI; Zimmerman TM; Gajewski TF; Stadler WM; Vogelzang NJ
    J Urol; 2001 Apr; 165(4):1208-9. PubMed ID: 11257677
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecularly targeted therapy in renal cell carcinoma: where do we go from here?
    Rini BI
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1753-60. PubMed ID: 17181489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma.
    Nelson RP; Logan TF; Abonour R
    Bone Marrow Transplant; 2002 Dec; 30(12):805-12. PubMed ID: 12476272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrectomy and interleukin-2 for metastatic renal-cell carcinoma.
    Pantuck AJ; Belldegrun AS; Figlin RA
    N Engl J Med; 2001 Dec; 345(23):1711-2. PubMed ID: 11759660
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted therapy for renal cell carcinoma: a new therapeutic paradigm.
    Shaheen PE; Bukowski RM
    Cancer Invest; 2006 Oct; 24(6):640-56. PubMed ID: 16982470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrectomy for metastatic renal-cell cancer.
    Bolger G
    N Engl J Med; 2002 Apr; 346(14):1095-6. PubMed ID: 11932483
    [No Abstract]   [Full Text] [Related]  

  • 17. Nephrectomy for metastatic renal-cell cancer.
    Copur MS; Ledakis P; Norvell M
    N Engl J Med; 2002 Apr; 346(14):1095-6. PubMed ID: 11936126
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunotherapy of renal cell carcinoma: results from current phase-III-trials].
    Doehn C; Jocham D
    Aktuelle Urol; 2004 Apr; 35(2):121-9. PubMed ID: 15146376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The end of chemotherapy in renal cell carcinoma: for much but not for all.
    Iacovelli R; Raimondi C; Palazzo A
    Am J Clin Oncol; 2010 Oct; 33(5):522-3. PubMed ID: 20924226
    [No Abstract]   [Full Text] [Related]  

  • 20. Design and Rationale of the Metastatic Renal Cell Carcinoma (MaRCC) Registry: A Prospective Academic and Community-Based Study of Patients With Metastatic Renal Cell Cancer.
    Bhavsar NA; Harrison MR; Hirsch BR; Creel P; Wolf SP; Samsa GP; Abernethy AP; Simantov R; Borham A; George DJ
    Cancer Invest; 2017 May; 35(5):333-344. PubMed ID: 28368708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.